HDL (high-density lipoprotein) ranges chart HDL Ranges (mg/dL)Risk Less than 40 mg/dL (men), less than 50 mg/dL (women) heart disease Greater than 60mg/dL some protection against heart disease LDL (low-density lipoprotein) ranges chart LDL Ranges (mg/dL)Risk Less than 100 optimal 10...
endocrinology, and primary care offices in 2015 and captured demographic data, lipid treatment history, and the highest LDL‐C level in the past 2 years. Core laboratory lipid levels were drawn at enrollment. Among 7627 p...
[4] LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvast...
Table 1 Baseline characteristics, statin and evolocumab use, and LDL-C levels in chart review assessment Full size table Fig. 2 Lipid-lowering therapy use in chart review assessment of evolocumab. High- and moderate-intensity statin and ezetimibe use before and after evolocumab initiation Full size...
LDL-C levels < 40 mg/mL were not routinely documented as being addressed in the chart by the clinician.Plummer, SarahWright, MeganBrown, J. MichaelFederal Practitioner
[4] LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425...
as well as various desirable numbers for each. Some cholesterol is considered good, while other cholesterol is considered bad. Consequently, their respective numbers have to stay over or under a particular level, based on the particular type. A cholesterol levels chart enables you to completely gra...
Low-density lipoprotein (LDL): This is often referred to as "bad" cholesterol because too much of it can build up in your arteries and formplaques, which increases the risk ofheart diseaseorstroke. As a general rule, you should keep LDL levels low to prevent plaque formation. ...
Jr., Maurice R., Pease R.J., Weech P.K., Rassart E., Fruchart J.C., Scott J., Marcel Y.L. The use of monoclonal antibodies to localize the low density lipoprotein receptor binding domain of apolipoprotein B∗ J. Biol. Chem., 264 (1989), pp. 19754-19760 View PDFView article...
There were statistically significant differences in term of dyslipidemia, TG, LDL-C, HDL-C, hemoglobin and platelet. No significant differences were observed for other variables between the two groups. Fig. 1 Flow chart of patient enrollment Full size image Table 1 Baseline characteristics of the ...